Genelux (GNLX) Assets Average (2023 - 2026)
Genelux (GNLX) posted Assets Average of $25.7 million for Q1 2026, up 16.78% on a QoQ basis from $22.0 million in Q4 2025.
Analysis
Genelux (GNLX) Assets Average (2023 - 2026) Analysis & Trends
Genelux has reported Assets Average for 4 years, with the latest figure at $25.7 million in Q1 2026.
- On a quarterly basis, Assets Average changed N/A year-over-year to $25.7 million in Q1 2026; TTM through Mar 2026 was $25.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $26.9 million, down 14.16% from the prior year.
- Assets Average was $25.7 million for Q1 2026 at Genelux, up from $22.0 million in the prior quarter.
- The five-year high for Assets Average was $42.7 million in Q3 2024, with the low at $22.0 million in Q4 2025.
- Average Assets Average over 4 years is $31.1 million, with a median of $29.8 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Assets Average climbed 21.01% in 2024, then tumbled 41.3% in 2025.
- Over 4 years, Assets Average stood at $31.0 million in 2023, then increased by 21.01% to $37.5 million in 2024, then sank by 41.3% to $22.0 million in 2025, then rose by 16.78% to $25.7 million in 2026.
- The last three Assets Average figures came in at $25.7 million (Q1 2026), $22.0 million (Q4 2025), and $28.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.51 Bn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - | 25.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 25.70 Mn |
| Dec 31, 2025 | 22.01 Mn |
| Sep 30, 2025 | 28.62 Mn |
| Dec 31, 2024 | 37.49 Mn |
| Sep 30, 2024 | 42.72 Mn |
| Jun 30, 2024 | 34.93 Mn |
| Mar 31, 2024 | 26.28 Mn |
| Dec 31, 2023 | 30.98 Mn |